142 related articles for article (PubMed ID: 2260339)
21. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
22. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P
J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540
[TBL] [Abstract][Full Text] [Related]
23. The safety of rapid valproic acid infusion.
Limdi NA; Faught E
Epilepsia; 2000 Oct; 41(10):1342-5. PubMed ID: 11051132
[TBL] [Abstract][Full Text] [Related]
24. Hemorrhagic pancreatitis in a young child following valproic acid therapy. Clinical and ultrasonic assessment.
Rosenberg HK; Ortega W
Clin Pediatr (Phila); 1987 Feb; 26(2):98-101. PubMed ID: 3100124
[TBL] [Abstract][Full Text] [Related]
25. Hypersensitivity to topiramate sprinkle capsules does not preclude the use of topiramate tablets.
Marsden D; Libretto SE
Paediatr Drugs; 2004; 6(2):133-5. PubMed ID: 15035654
[No Abstract] [Full Text] [Related]
26. Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial.
Sherard ES; Steiman GS; Couri D
Neurology; 1980 Jan; 30(1):31-5. PubMed ID: 6985721
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal tolerance of divalproex sodium.
Wilder BJ; Karas BJ; Penry JK; Asconape J
Neurology; 1983 Jun; 33(6):808-11. PubMed ID: 6405304
[TBL] [Abstract][Full Text] [Related]
28. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature.
Kamenetsky Z; Da'as N; Esayag Y; Kleinman Y; Samuels N
Neurologist; 2012 Jan; 18(1):39-40. PubMed ID: 22217614
[TBL] [Abstract][Full Text] [Related]
29. Fatal acute pancreatitis caused by valproic acid.
Evans RJ; Miranda RN; Jordan J; Krolikowski FJ
Am J Forensic Med Pathol; 1995 Mar; 16(1):62-5. PubMed ID: 7771387
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion.
Cook AM; Zafar MS; Mathias S; Stewart AM; Albuja AC; Bensalem-Owen M; Kapoor S; Baumann RJ
CNS Drugs; 2016 Jan; 30(1):71-7. PubMed ID: 26715390
[TBL] [Abstract][Full Text] [Related]
31. Valproate-associated acute pancreatitis in a child with neuronal ceroid lipofuscinosis.
Talwar D
J Child Neurol; 1994 Jan; 9(1):36-7. PubMed ID: 8151078
[TBL] [Abstract][Full Text] [Related]
32. Your role in valproic acid therapy.
Gever LN
Nursing; 1982 Jun; 12(6):104-6. PubMed ID: 6806728
[No Abstract] [Full Text] [Related]
33. Hypoalbuminemia with valproic acid administration.
Rugino TA; Janvier YM; Baunach JM; Bilat CA
Pediatr Neurol; 2003 Nov; 29(5):440-4. PubMed ID: 14684241
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effectiveness of several formulations of sodium valproate: tablets, enteric-coated capsules, solutions and rectal capsules.
Battino D; Biraghi M; Cusi C; Nespolo A; Avanzini G
Ital J Neurol Sci; 1982 Oct; 3(3):197-200. PubMed ID: 6819250
[TBL] [Abstract][Full Text] [Related]
35. Comment: sorbitol in oral liquids.
Johnston KR; Govel LA; Andritz MH
Ann Pharmacother; 1993 Sep; 27(9):1143. PubMed ID: 8219457
[No Abstract] [Full Text] [Related]
36. Urine Incontinence Induced by Valproic Acid.
Sudan YS; Bansal AR
Indian J Pediatr; 2017 Nov; 84(11):867-868. PubMed ID: 28577199
[No Abstract] [Full Text] [Related]
37. Necrotizing pancreatitis after 10 years of therapy with valproic acid.
Tobias JD; Capers C; Sims P; Holcomb GW
Clin Pediatr (Phila); 1995 Aug; 34(8):446-8. PubMed ID: 7586914
[No Abstract] [Full Text] [Related]
38. Gastrointestinal effects of sorbitol as an additive in liquid medications.
Johnston KR; Govel LA; Andritz MH
Am J Med; 1994 Aug; 97(2):185-91. PubMed ID: 8059785
[TBL] [Abstract][Full Text] [Related]
39. L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.
Maldonado C; Guevara N; Silveira A; Fagiolino P; Vázquez M
J Int Med Res; 2017 Jun; 45(3):1268-1272. PubMed ID: 28425821
[TBL] [Abstract][Full Text] [Related]
40. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
Ertam I; Sezgin AO; Unal I
Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
